RAISING CAPITAL
Project Evergreen | Regenerative & Longevity Clinic Under LOI | $4.8M 2026E Adj. EBITDA
Healthcare · Midwest, US
revenue: $10,600,000
ebitda: $4,800,000
Exclusivity:
Non-Exclusive Deal
SBA Eligiblity:
Not SBA Eligible
Revenue:
$10,600,000
EBITDA:
$4,800,000
Alta Ridge Partners is raising capital for an independent sponsor that has a founder led regenerative and longevity medicine clinic in the Midwest under LOI. The Deal • Sponsor buys 70% at a $16.1M purchase price: 3.4x 2026E Adj. EBITDA of $4.8M (6.1x 2025A) • Founder rolls 30% and stays on as Medical Director; LOI includes a seller note • Indicative stack: $8.9M senior debt (2.0x LTM Adj. EBITDA) and $5.4M new equity • Sponsor is open to other debt and equity mixes, including one combined check The Business • Founded in 2023 by a clinician who previously built a regenerative medicine group to 15 locations in five states • Surgery free stem cell, PRP, hormone, GLP 1 weight loss, peptide and physical therapy protocols • ~76% of revenue is cash pay; ~30% of new patients come from out of state • 2 clinics (second opened in 2026), 28 staff, running at ~41% of capacity Financials • 2025A: $7.0M revenue (+94%), $2.6M Adj. EBITDA, 38% margin • 2026E: $10.6M revenue (+52%), $4.8M Adj. EBITDA, 45% margin • $2.9M cash vs. $0.5M total liabilities (QoE validated) Teaser attached. The CIM and data room are available after signing an NDA. Message me here or email redacted